Concepedia

Nenad Svrzikapa

NS

Statistics

Publications

15

Citations

3.9K

H-Index

13

Active since

2005

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Wave Life Sciences (United States)

Alnylam Pharmaceuticals (United States)

Simon Fraser University

Nenad Svrzikapa is an author at Dana-Farber Cancer Institute specializing in medicine, genetics, and molecular genetics.

ORCID

Top concepts

Publications per year

2005–2022

15

Publications

15

High-Quality Binary Protein Interaction Map of the Yeast Interactome Network

Haiyuan Yu, Pascal Falter‐Braun, Muhammed A. Yıldırım et al. · Science · 2008 · 1.4K citations · Full text

First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

Josep Tabernero, Geoffrey I. Shapiro, Patricia LoRusso et al. · Cancer Discovery · 2013 · 691 citations

JNK regulates lifespan in <i>Caenorhabditis elegans</i> by modulating nuclear translocation of forkhead transcription factor/DAF-16

Seung Wook Oh, Arnab Mukhopadhyay, Nenad Svrzikapa et al. · Proceedings of the National Academy of Sciences · 2005 · 523 citations · Full text

Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides

Naoki Iwamoto, David C. Butler, Nenad Svrzikapa et al. · Nature Biotechnology · 2017 · 358 citations

, , +7

Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans

Denis Dupuy, Nicolas Bertin, César A. Hidalgo et al. · Nature Biotechnology · 2007 · 289 citations

, , +8

Rows per page

1–5 of 15